β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An Overview.

Antibiotic ESKAPE PBP Peptidoglycan Resistance β-Lactam

Journal

Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 21 12 2022
accepted: 30 01 2023
pubmed: 7 3 2023
medline: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Bacteria acquire β-lactam resistance through a multitude of mechanisms among which production of β-lactamases (enzymes that hydrolyze β-lactams) is the most common, especially in Gram-negatives. Structural changes in the high-molecular-weight, essential penicillin-binding proteins (PBPs) are widespread in Gram-positives and increasingly reported in Gram-negatives. PBP-mediated resistance is largely achieved by accumulation of mutation(s) resulting in reduced binding affinities of β-lactams. Herein, we discuss PBP-mediated resistance among ESKAPE pathogens that cause diverse hospital- and community-acquired infections globally.

Identifiants

pubmed: 36877435
doi: 10.1007/s40121-023-00771-8
pii: 10.1007/s40121-023-00771-8
pmc: PMC10017896
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

829-841

Informations de copyright

© 2023. The Author(s).

Références

J Antimicrob Chemother. 2017 May 1;72(5):1373-1385
pubmed: 28158732
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137811
J Antimicrob Chemother. 2018 Jun 1;73(6):1530-1536
pubmed: 29566147
Ann Biol Clin (Paris). 1989;47(5):231-6
pubmed: 2742218
Front Microbiol. 2015 May 18;6:392
pubmed: 26042091
J Mol Biol. 2019 Aug 23;431(18):3472-3500
pubmed: 30959050
Antimicrob Agents Chemother. 2015 Dec;59(12):7753-61
pubmed: 26438498
Ther Clin Risk Manag. 2016 May 19;12:787-97
pubmed: 27279744
FEBS Lett. 1977 Jul 15;79(2):374-8
pubmed: 330236
J Antimicrob Chemother. 2020 Jun 1;75(6):1650-1651
pubmed: 32040179
J Biol Chem. 1999 Nov 5;274(45):32031-9
pubmed: 10542235
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27821450
EBioMedicine. 2020 May;55:102771
pubmed: 32344200
J Biol Chem. 1976 Jan 25;251(2):414-23
pubmed: 1391
Cell. 2014 Dec 4;159(6):1300-11
pubmed: 25480295
Antimicrob Agents Chemother. 2019 Oct 7;:
pubmed: 31591114
Front Cell Infect Microbiol. 2019 Jan 04;8:446
pubmed: 30662878
Drugs. 2014 Jan;74(1):31-51
pubmed: 24352909
FEMS Microbiol Rev. 2006 Sep;30(5):673-91
pubmed: 16911039
FEMS Microbiol Rev. 2017 May 1;41(3):252-275
pubmed: 28521338
J Glob Antimicrob Resist. 2022 Sep;30:445-450
pubmed: 35618210
Am J Med. 1996 Jun 24;100(6A):45S-51S
pubmed: 8678097
J Bacteriol. 1981 Jan;145(1):333-40
pubmed: 6450748
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29712652
IUBMB Life. 2014 Aug;66(8):572-7
pubmed: 25044998
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27821444
Int J Antimicrob Agents. 2017 Feb;49(2):239-242
pubmed: 27939093
FEMS Microbiol Rev. 2008 Mar;32(2):234-58
pubmed: 18266856
Antimicrob Agents Chemother. 2015;59(6):3548-55
pubmed: 25845878
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27091943
Antimicrob Agents Chemother. 1991 Mar;35(3):477-83
pubmed: 1674848
J Bacteriol. 1978 Dec;136(3):1143-58
pubmed: 363690
Exp Ther Med. 2020 Apr;19(4):2449-2456
pubmed: 32256721
Proc Natl Acad Sci U S A. 1981 Sep;78(9):5856-60
pubmed: 7029548
Antimicrob Agents Chemother. 2007 Apr;51(4):1481-6
pubmed: 17283197
PLoS One. 2015 Sep 23;10(9):e0138828
pubmed: 26398358
Biochem Biophys Res Commun. 2004 May 7;317(3):851-6
pubmed: 15081418
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30323035
J Bacteriol. 1981 Jan;145(1):632-7
pubmed: 7007327
Antimicrob Agents Chemother. 2015 Jul;59(7):3925-34
pubmed: 25896695
Proc Natl Acad Sci U S A. 1975 Aug;72(8):2999-3003
pubmed: 1103132
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5632-5
pubmed: 3898066
J Bacteriol. 1994 Jan;176(1):256-9
pubmed: 8282705
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061284
Antimicrob Agents Chemother. 2010 Nov;54(11):4900-2
pubmed: 20805396
mSphere. 2019 Jul 3;4(4):
pubmed: 31270174
J Antimicrob Chemother. 2015 May;70(5):1420-8
pubmed: 25634992
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2319-2327
pubmed: 28748397
Antimicrob Agents Chemother. 2011 Dec;55(12):5907-13
pubmed: 21947403
Eur J Biochem. 1994 Sep 1;224(2):597-604
pubmed: 7925376
Clin Infect Dis. 1995 Nov;21(5):1107-13
pubmed: 8589129
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28320724
Nature. 1975 Apr 10;254(5500):516-7
pubmed: 1091862
Front Microbiol. 2016 Oct 06;7:1581
pubmed: 27766095
Mol Microbiol. 2001 Jul;41(1):189-98
pubmed: 11454211
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28559260
Ann Intern Med. 1991 Oct 15;115(8):585-90
pubmed: 1892329

Auteurs

Dhiviya Prabaa Muthuirulandi Sethuvel (DPM)

Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.

Yamuna Devi Bakthavatchalam (YD)

Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.

Maruthan Karthik (M)

Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.

Madhumathi Irulappan (M)

Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.

Rahul Shrivastava (R)

Wockhardt Research Centre, Aurangabad, India.

Hariharan Periasamy (H)

Wockhardt Research Centre, Aurangabad, India.

Balaji Veeraraghavan (B)

Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India. vbalaji@cmcvellore.ac.in.

Classifications MeSH